Human Molecular Genetics, 2000, Vol. 9, No. 19 2837-2844
© 2000 Oxford University Press
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia
1Department of Internal Medicine and 2Department of Nutrition, University of California, Davis, CA 95616, USA, 3Oxford Project to Investigate Memory and Ageing, Department of Pharmacology and 4Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 3QT, UK
Low blood folate levels result in hyperhomocysteinemia, which has been associated with increased risk for cardiovascular disease, neural tube defects and cognitive deficits. Intake of dietary folates is the chief determinant of blood folate levels. Molecular defects in the intestinal absorption of dietary folates that precipitate low blood folate levels and hyperhomocysteinemia have not been investigated previously. Dietary folates are a mixture of polyglutamylated folates which are digested to monoglutamyl folates by the action of folylpoly-
-glutamate carboxypeptidase (FGCP), an enzyme that is anchored to the intestinal brush border membrane and is expressed by the glutamate carboxypepidase II (GCPII) gene. We cloned GCPII cDNA from human intestine and identified both a full-length transcript and a 93 bp shorter transcript lacking exon 18, consistent with the presence of a splice variant. In addition, we identified an H475Y polymorphism in GCPII in DNA samples from a healthy Caucasian population (n = 75). We found that membranes of transfected COS-7 cells expressing the H475Y variant GCPII cDNA had 53% less FGCP activity than did cells expressing wild-type GCPII. The presence of the H475Y GCPII allele was significantly associated with lower folate and higher homocysteine levels in this population. These data suggest that the presence of the H475Y GCPII allele impairs the intestinal absorption of dietary folates, resulting in relatively low blood folate levels and consequent hyperhomocysteinemia.
+ To whom correspondence should be addressed. Tel: +1 530 752 6778; Fax: +1 530 752 3470; Email: chhalsted@ucdavis.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. DeVos, A. Chanson, Z. Liu, E. D Ciappio, L. D Parnell, J. B Mason, K. L Tucker, and J. W Crott Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1149 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H Halsted, D. H Wong, J. M Peerson, C. H Warden, H. Refsum, A D. Smith, O. K Nygard, P. M Ueland, S. E Vollset, and G. S Tell Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, August 1, 2007; 86(2): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hazra, K. Wu, P. Kraft, C. S. Fuchs, E. L. Giovannucci, and D. J. Hunter Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study Carcinogenesis, July 1, 2007; 28(7): 1510 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koushik, P. Kraft, C. S. Fuchs, S. E. Hankinson, W. C. Willett, E. L. Giovannucci, and D. J. Hunter Nonsynonymous Polymorphisms in Genes in the One-Carbon Metabolism Pathway and Associations with Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2408 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Devlin, R. Clarke, J. Birks, J. G. Evans, and C. H Halsted Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population Am. J. Clinical Nutrition, March 1, 2006; 83(3): 708 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melse-Boonstra, K. J. Lievers, H. J Blom, and P. Verhoef Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene Am. J. Clinical Nutrition, September 1, 2004; 80(3): 700 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Goff, T. Bottiglieri, E. Arning, V. Shih, O. Freudenreich, A. E. Evins, D. C. Henderson, L. Baer, and J. Coyle Folate, Homocysteine, and Negative Symptoms in Schizophrenia Am J Psychiatry, September 1, 2004; 161(9): 1705 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C L Relton, C S Wilding, M S Pearce, A J Laffling, P A Jonas, S A Lynch, E J Tawn, and J Burn Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population J. Med. Genet., April 1, 2004; 41(4): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fodinger, J. Dierkes, S. Skoupy, C. Rohrer, W. Hagen, H. Puttinger, A.-C. Hauser, A. Vychytil, and G. Sunder-Plassmann Effect of Glutamate Carboxypeptidase II and Reduced Folate Carrier Polymorphisms on Folate and Total Homocysteine Concentrations in Dialysis Patients J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Afman, F. J. M. Trijbels, and H. J. Blom The H475Y Polymorphism in the Glutamate Carboxypeptidase II Gene Increases Plasma Folate without Affecting the Risk for Neural Tube Defects in Humans J. Nutr., January 1, 2003; 133(1): 75 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Halsted, J. A. Villanueva, A. M. Devlin, and C. J. Chandler Metabolic Interactions of Alcohol and Folate J. Nutr., August 1, 2002; 132(8): 2367S - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vargas-Martinez, J. M. Ordovas, P. W. Wilson, and J. Selhub The Glutamate Carboxypeptidase Gene II (C>T) Polymorphism Does Not Affect Folate Status in The Framingham Offspring Cohort J. Nutr., June 1, 2002; 132(6): 1176 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Gregory III Case Study: Folate Bioavailability J. Nutr., April 1, 2001; 131(4): 1376S - 1382. [Abstract] [Full Text] |
||||






